
Biocon Limited has informed the Exchange regarding a press release dated January 06, 2026, titled "Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference.".
Filed with NSE · · 4 pages · English

Biocon Limited has informed the Exchange regarding a press release dated January 06, 2026, titled "Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference.".
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon